• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶III变异杂合子患者的脑梗死

Cerebral infarction in a heterozygote with variant antithrombin III.

作者信息

Arima T, Motomura M, Nishiura Y, Tsujihata M, Okajima K, Abe H, Nagataki S

机构信息

First Department of Internal Medicine, Nagasaki University Medical School, Japan.

出版信息

Stroke. 1992 Dec;23(12):1822-5. doi: 10.1161/01.str.23.12.1822.

DOI:10.1161/01.str.23.12.1822
PMID:1448834
Abstract

BACKGROUND

We report a heterozygous case of familial qualitative deficiency of antithrombin III associated with cerebral infarction.

CASE DESCRIPTION

A 33-year-old man had a history of recurrent transient ischemic attacks from the age of 28. Cerebral computed tomography at age 29 disclosed a low-density area in the left frontal lobe, and an internal carotid angiogram showed branch occlusion of the right anterior cerebral artery and stenosis of the left middle cerebral artery. Occlusion of the right middle cerebral artery developed thereafter. The plasma antithrombin III antigen concentration and progressive antithrombin activity were normal, but plasma heparin cofactor activity was low in the patient and his father. Nucleotide sequence analysis of the proband's deoxyribonucleic acid showed no mutation in exons II and VI of antithrombin III.

CONCLUSIONS

We conclude that abnormal antithrombin III with defective heparin binding, even though heterozygous, may cause ischemic stroke in young adults. We named this antithrombin III variant "Antithrombin III Nagasaki."

摘要

背景

我们报告了1例与脑梗死相关的家族性抗凝血酶III质量缺陷杂合病例。

病例描述

一名33岁男性自28岁起有反复发作短暂性脑缺血发作病史。29岁时脑部计算机断层扫描显示左额叶有低密度区,颈内动脉血管造影显示右大脑前动脉分支闭塞和左大脑中动脉狭窄。此后右大脑中动脉发生闭塞。患者及其父亲的血浆抗凝血酶III抗原浓度和抗凝血酶活性正常,但血浆肝素辅因子活性较低。先证者脱氧核糖核酸的核苷酸序列分析显示抗凝血酶III的外显子II和VI无突变。

结论

我们得出结论,即使是杂合状态,具有肝素结合缺陷的异常抗凝血酶III也可能导致年轻成年人发生缺血性卒中。我们将这种抗凝血酶III变异体命名为“长崎抗凝血酶III”。

相似文献

1
Cerebral infarction in a heterozygote with variant antithrombin III.抗凝血酶III变异杂合子患者的脑梗死
Stroke. 1992 Dec;23(12):1822-5. doi: 10.1161/01.str.23.12.1822.
2
Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
Blood. 1993 Mar 1;81(5):1300-5.
3
[Familial antithrombin III abnormality accompanied with progressing ischemic stroke].[伴有进行性缺血性卒中的家族性抗凝血酶III异常]
Rinsho Shinkeigaku. 1989 Apr;29(4):450-5.
4
Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.抗凝血酶III熊本II型;精氨酸393位点突变为组氨酸增加了抗凝血酶III对肝素的亲和力。
Am J Hematol. 1995 Jan;48(1):12-8. doi: 10.1002/ajh.2830480104.
5
[A case of familial antithrombin III variant complicated by recurrent pulmonary infarction].1例家族性抗凝血酶III变异体合并复发性肺梗死
Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Feb;31(2):214-8.
6
Homozygous or compound heterozygous qualitative antithrombin III deficiency.纯合子或复合杂合子性抗凝血酶III定性缺乏症。
Nouv Rev Fr Hematol (1978). 1994 Aug;36(4):335-7.
7
[Hemorrhagic cerebral infarction at the old age in a case with familial antithrombin III (ATIII) deficiency].
Rinsho Shinkeigaku. 1995 Jan;35(1):87-9.
8
Antithrombin III deficiency.
Rom J Intern Med. 1994 Apr-Jun;32(2):119-27.
9
Ischemic stroke in congenital (type II C) defective antithrombin III.先天性(II C型)抗凝血酶III缺陷导致的缺血性中风。
Int J Clin Lab Res. 1993;23(4):212-4. doi: 10.1007/BF02592311.
10
Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.抗凝血酶长崎型(第116位丝氨酸突变为脯氨酸):一种罕见的抗凝血酶变体,在孕期出现肝素结合异常。
Blood Coagul Fibrinolysis. 2006 Apr;17(3):217-20. doi: 10.1097/01.mbc.0000220246.20036.f6.

引用本文的文献

1
Bilateral renal artery thrombosis in inherited thrombophilia: a rare cause of acute kidney injury.遗传性易栓症中的双侧肾动脉血栓形成:急性肾损伤的罕见原因。
Int J Nephrol Renovasc Dis. 2014 Jan 18;7:35-8. doi: 10.2147/IJNRD.S50948.